Endovascular Treatment with Limus Eluting Stents in Patients with Acute Coronary Syndrome
BACKGROUND Coronary heart disease is one of the main causes of the population’s disability and mortality in Russia and abroad. Revascularization with coronary stents in the course of the most suitable drug therapy is one of the most important treatments of coronary heart disease. It is essential to...
Saved in:
Main Authors: | M. V. Chernyayev, A. G. Faybushevich, Y. S. Muzganova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Sklifosovsky Research Institute for Emergency Medicine, Public Healthcare Institution of Moscow Healthcare Department
2019-04-01
|
Series: | Неотложная медицинская помощь |
Subjects: | |
Online Access: | https://www.jnmp.ru/jour/article/view/586 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and Efficacy of Cobalt Chromium Everolimus‐Eluting Stents for Treatment of In‐Stent Restenosis: An ILUMIEN IV Substudy
by: Ziad A. Ali, et al.
Published: (2025-06-01) -
Role of early increase in vascular endothelial growth factor-A levels after coronary stenting in the development of drug-eluting in-stent restenosis
by: V. V. Tishko, et al.
Published: (2024-06-01) -
Impact of Arterial Stiffness on In-Stent Restenosis in the Era of Drug-Eluting Stents
by: Yiquan Huang, et al.
Published: (2025-06-01) -
Long term outcomes of drug-coated balloons versus drug-eluting stents in patients with small vessel coronary artery disease
by: Hesham Refaat, et al.
Published: (2025-07-01) -
How real is a threat of late thrombosis for drug-eluting stents? Stent comparison and focus on everolimus
by: V. P. Lupanov, et al.
Published: (2009-10-01)